BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2327468)

  • 1. Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
    Sharp GB; Cole P
    Am J Obstet Gynecol; 1990 Apr; 162(4):994-1001. PubMed ID: 2327468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring.
    Robboy SJ; Young RH; Welch WR; Truslow GY; Prat J; Herbst AL; Scully RE
    Cancer; 1984 Sep; 54(5):869-75. PubMed ID: 6537153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of nuclear DNA in vaginal adenosis and clear-cell adenocarcinoma.
    Lewis JL; Nordqvist SR; Richart RM
    Am J Obstet Gynecol; 1973 Mar; 115(6):737-50. PubMed ID: 4688576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethylstilbestrol-associated vaginal adenosis followed by clear cell adenocarcinoma.
    Sander R; Nuss RC; Rhatigan RM
    Int J Gynecol Pathol; 1986; 5(4):362-70. PubMed ID: 3643169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of prenatal diethylstilbestrol exposure.
    Welch WR; Prat J; Robboy SJ; Herbst AL
    Pathol Annu; 1978; 13 Pt 1():201-16. PubMed ID: 364384
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero.
    Poskanzer DC; Herbst AL
    Cancer; 1977 Apr; 39(4 Suppl):1892-5. PubMed ID: 856457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning and transmission electron microscopic studies of vaginal adenosis and the cervical transformation zone in progeny exposed in utero to diethylstilbestrol.
    Fenoglio CM; Ferenczy A; Richart RM; Townsend D
    Am J Obstet Gynecol; 1976 Sep; 126(2):170-80. PubMed ID: 961758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.